Qlucore AB (publ) (STO:QCORE)
0.8300
-0.1350 (-13.99%)
Jul 31, 2025, 3:37 PM CET
Verve Therapeutics Balance Sheet
Financials in millions SEK. Fiscal year is May - April.
Millions SEK. Fiscal year is May - Apr.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | 2019 - 2020 |
Cash & Equivalents | 5.26 | 28.62 | 69.73 | 97.97 | 27.56 | Upgrade |
Cash & Short-Term Investments | 5.26 | 28.62 | 69.73 | 97.97 | 27.56 | Upgrade |
Cash Growth | -81.63% | -58.96% | -28.82% | 255.49% | 516.26% | Upgrade |
Accounts Receivable | 2.87 | 4.24 | 2.2 | 2.41 | 2.83 | Upgrade |
Other Receivables | 4.22 | 0.66 | 1.34 | 0.67 | 0.64 | Upgrade |
Receivables | 7.09 | 4.91 | 3.54 | 3.08 | 3.47 | Upgrade |
Prepaid Expenses | - | 2.48 | 0.57 | 0.6 | 0.41 | Upgrade |
Other Current Assets | - | 0 | - | -0 | - | Upgrade |
Total Current Assets | 12.34 | 36 | 73.84 | 101.65 | 31.45 | Upgrade |
Property, Plant & Equipment | 0.16 | 0.36 | 0.49 | 0.56 | 0.26 | Upgrade |
Other Intangible Assets | 57.45 | 53.65 | 35.03 | 19.69 | 14.53 | Upgrade |
Other Long-Term Assets | - | -0 | - | -0 | 0 | Upgrade |
Total Assets | 69.95 | 90.01 | 109.36 | 121.9 | 46.24 | Upgrade |
Accounts Payable | 0.36 | 2.16 | 4.36 | 1.57 | 1.08 | Upgrade |
Accrued Expenses | - | 2.75 | 3.35 | 2.24 | 1.92 | Upgrade |
Short-Term Debt | - | - | - | - | 1.5 | Upgrade |
Current Portion of Long-Term Debt | 0.6 | 1.18 | 1.28 | 0.88 | 0.88 | Upgrade |
Current Unearned Revenue | - | 1.43 | 2.26 | 1.43 | 0.38 | Upgrade |
Other Current Liabilities | 9.13 | 1.37 | 0.21 | 0.77 | 1.66 | Upgrade |
Total Current Liabilities | 10.09 | 8.9 | 11.44 | 6.88 | 7.42 | Upgrade |
Long-Term Debt | 1.4 | 2 | 3.18 | 4.46 | 2.26 | Upgrade |
Other Long-Term Liabilities | - | - | 0 | - | - | Upgrade |
Total Liabilities | 11.49 | 10.9 | 14.63 | 11.34 | 9.68 | Upgrade |
Common Stock | 0.77 | 0.77 | 0.77 | 0.77 | 0.26 | Upgrade |
Additional Paid-In Capital | 131.94 | 131.94 | 131.94 | 131.88 | 46.59 | Upgrade |
Retained Earnings | -74.24 | -53.6 | -37.98 | -22.08 | -10.29 | Upgrade |
Comprehensive Income & Other | - | - | -0 | - | - | Upgrade |
Shareholders' Equity | 58.47 | 79.11 | 94.73 | 110.56 | 36.56 | Upgrade |
Total Liabilities & Equity | 69.95 | 90.01 | 109.36 | 121.9 | 46.24 | Upgrade |
Total Debt | 2 | 3.18 | 4.46 | 5.33 | 4.64 | Upgrade |
Net Cash (Debt) | 3.26 | 25.44 | 65.27 | 92.64 | 22.92 | Upgrade |
Net Cash Growth | -87.19% | -61.03% | -29.54% | 304.10% | - | Upgrade |
Net Cash Per Share | 0.81 | 6.31 | 16.20 | 23.00 | 8.71 | Upgrade |
Filing Date Shares Outstanding | 4.03 | 4.03 | 4.03 | 4.03 | 2.63 | Upgrade |
Total Common Shares Outstanding | 4.03 | 4.03 | 4.03 | 4.03 | 2.63 | Upgrade |
Working Capital | 2.26 | 27.1 | 62.4 | 94.77 | 24.03 | Upgrade |
Book Value Per Share | 14.51 | 19.64 | 23.52 | 27.45 | 13.89 | Upgrade |
Tangible Book Value | 1.01 | 25.46 | 59.7 | 90.87 | 22.03 | Upgrade |
Tangible Book Value Per Share | 0.25 | 6.32 | 14.82 | 22.56 | 8.37 | Upgrade |
Machinery | - | 1.58 | 1.8 | 1.58 | 1.03 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.